2023.11.18Vol.5 No.14 ICH Uploaded in the HiroPharma [REFERENCE] Page : (Japanese translated version) Pre- and post-marketing safety reports to the FDA using ICH E2B(R3) Guideline : "November 7, 2023 FDA Public Meeting Webinar Report"
2023.03.10Vol.5 No.5 ICH Reporting Individual Case Study Reports (ICSRs) to FDA Adverse event Reporting System (FAERS) Using ICH E2B R3 Standards [Webinar Document 13-Jan-2023] uploaded on REFERENCE Page
2020.02.09Vol.1 No.9 ICH FDA 3rd Public Meeting “Electronic Adverse Event Reporting to FDA (R3) Using ICH E2B (FAERS-II)”
